Actively Recruiting
BETTY: BEnign Prostatic Hyperplasia Transperineal Targeted Microwave therapY
Led by Chinese University of Hong Kong · Updated on 2025-05-06
12
Participants Needed
1
Research Sites
185 weeks
Total Duration
On this page
Sponsors
C
Chinese University of Hong Kong
Lead Sponsor
K
Koelis
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is a pilot study on applying 3D-Ultrasound-Guided Transperineal Microwave needle ablation for men with symptomatic benign prostatic hyperplasia (BPH).
CONDITIONS
Official Title
BETTY: BEnign Prostatic Hyperplasia Transperineal Targeted Microwave therapY
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age over 50 years
- Benign prostatic hyperplasia with prostate size 30-80 cc
- International Prostate Symptom Score (IPSS) of 14 or higher
- Prostate-specific antigen (PSA) 4 ng/mL or less, or PSA above 4 ng/mL with no suspicious lesion on mpMRI
- Maximum urine flow rate (Qmax) 15 mL/s or less
- Post-void residual urine volume 150 mL or less
- Suitable for intravenous sedation, spinal anesthesia, or general anesthesia and focal microwave ablation
- Able to provide informed written consent
You will not qualify if you...
- Significant intravesical median lobe hyperplasia
- Suspicious lesion on mpMRI prostate
- History of prostate, bladder, or urethral surgery
- History of prostate cancer
- Presence of stones, bladder diverticulum, or bladder tumor
- History of long-term indwelling catheter
- Urethral stricture
- Known coagulopathy or use of anticoagulants
- Presence of a pacemaker
- Active infection
- Dysuria caused by bladder dysfunction
- Serious medical illness such as uncontrolled congestive heart failure, uncontrolled angina, recent myocardial infarction or cerebrovascular event within 6 months
- Neurological disorders affecting bladder function (e.g., multiple sclerosis, Parkinson's disease, spinal cord injury)
- Contraindications for mpMRI exam or MR contrast
- Acute or chronic renal failure with GFR less than 50 ml/min and serum creatinine over 1.5 mg/dL
- Currently participating in another interventional clinical trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Prince of Wales Hospital
Hong Kong, Hong Kong
Actively Recruiting
Research Team
P
Peter Ka-Fung CHIU, FRCS, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here